Tag: Alucent Biomedical
Alucent Biomedical granted US FDA approval for clinical study
Alucent Biomedical has announced that the US Food and Drug Administration (FDA) granted an investigational device exemption (IDE) for a US clinical study of...
Alucent Biomedical adds to scientific advisory board, expands portfolio with AF...
Alucent Biomedical has announced Stanford vascular surgeon Venita Chandra (Stanford University Medical Center, Stanford, USA) will join the company’s scientific advisory board. The news...
Alucent Biomedical announces US$35 million Series B financing
Alucent Biomedical recently announced the close of a US$35 million Series B financing round led by a large multinational strategic investor and joined by...
Alucent Biomedical announces FDA approval to proceed with natural vascular scaffolding...
Alucent Biomedical has received US Food and Drug Administration (FDA) approval to proceed with a phase 1 clinical trial to evaluate the safety and...
